ACG Clinical Guideline: Ulcerative Colitis in Adults

被引:1357
作者
Rubin, David T. [1 ]
Ananthakrishnan, Ashwin N. [2 ]
Siegel, Corey A. [3 ]
Sauer, Bryan G. [4 ]
Long, Millie D. [5 ]
机构
[1] Univ Chicago Med, Inflammatory Bowel Dis Ctr, Chicago, IL 60637 USA
[2] Massachusetts Gen Hosp, Crohns & Colitis Ctr, Div Gastroenterol, Boston, MA 02114 USA
[3] Dartmouth Hitchcock Med Ctr, Sect Gastroenterol & Hepatol, Lebanon, NH 03766 USA
[4] Univ Virginia, Dept Med, Charlottesville, VA USA
[5] Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC 27515 USA
关键词
INFLAMMATORY-BOWEL-DISEASE; C-REACTIVE PROTEIN; CLOSTRIDIUM-DIFFICILE INFECTION; TERM-FOLLOW-UP; FECAL MICROBIOTA TRANSPLANTATION; RANDOMIZED CONTROLLED-TRIAL; REPORTED OUTCOME MEASURES; ORAL TACROLIMUS FK506; DOUBLE-BLIND; ENDOSCOPIC INDEX;
D O I
10.14309/ajg.0000000000000152
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Ulcerative colitis (UC) is an idiopathic inflammatory disorder. These guidelines indicate the preferred approach to the management of adults with UC and represent the official practice recommendations of the American College of Gastroenterology. The scientific evidence for these guidelines was evaluated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) process. In instances where the evidence was not appropriate for GRADE, but there was consensus of significant clinical merit, key concept statements were developed using expert consensus. These guidelines are meant to be broadly applicable and should be viewed as the preferred, but not only, approach to clinical scenarios.
引用
收藏
页码:384 / 413
页数:30
相关论文
共 269 条
[71]
Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease [J].
Evans, JMM ;
McMahon, AD ;
Murray, FE ;
McDevitt, DG ;
MacDonald, TM .
GUT, 1997, 40 (05) :619-622
[72]
CLINICAL-PATTERNS, NATURAL-HISTORY, AND PROGRESSION OF ULCERATIVE-COLITIS - A LONG-TERM FOLLOW-UP OF 1116 PATIENTS [J].
FARMER, RG ;
EASLEY, KA ;
RANKIN, GB .
DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (06) :1137-1146
[73]
ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease [J].
Farraye, Francis A. ;
Melmed, Gil Y. ;
Lichtenstein, Gary R. ;
Kane, Sunanda V. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 (02) :241-258
[74]
Farraye FA, 2010, GASTROENTEROLOGY, V138, P746, DOI [10.1053/j.gastro.2009.12.035, 10.1053/j.gastro.2009.12.037]
[75]
FDA.gov, FDA BRIEF DOC GASTR
[76]
Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists [J].
Feagan, Brian G. ;
Rubin, David T. ;
Danese, Silvio ;
Vermeire, Severine ;
Abhyankar, Brihad ;
Sankoh, Serap ;
James, Alexandra ;
Smyth, Michael .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (02) :229-+
[77]
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis [J].
Feagan, Brian G. ;
Rutgeerts, Paul ;
Sands, Bruce E. ;
Hanauer, Stephen ;
Colombel, Jean-Frederic ;
Sandborn, William J. ;
Van Assche, Gert ;
Axler, Jeffrey ;
Kim, Hyo-Jong ;
Danese, Silvio ;
Fox, Irving ;
Milch, Catherine ;
Sankoh, Serap ;
Wyant, Tim ;
Xu, Jing ;
Parikh, Asit .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (08) :699-710
[78]
Are There Any Differences in the Efficacy and Safety of Different Formulations of Oral 5-ASA Used for Induction and Maintenance of Remission in Ulcerative Colitis? Evidence from Cochrane Reviews [J].
Feagan, Brian G. ;
Chande, Nilesh ;
MacDonald, John K. .
INFLAMMATORY BOWEL DISEASES, 2013, 19 (09) :2031-2040
[79]
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis [J].
Feagan, Brian G. ;
MacDonald, John K. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (10)
[80]
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis [J].
Feagan, Brian G. ;
MacDonald, John K. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (10)